Literature DB >> 34619514

T cell responses during HBV and HCV infections: similar but not quite the same?

Naglaa H Shoukry1, Christopher M Walker2.   

Abstract

The hepatitis B and C viruses persist by evasion of T cell immunity. Persistence depends upon premature failure of CD4+ T cell help and loss of CD8+ T cell control because of epitope mutational escape and/or functional exhaustion. Powerful new immunological and transcriptomic tools provide insight into the mechanisms of T cell silencing by HBV and HCV. Similarities are apparent, including dysregulated expression of common inhibitory/immune checkpoint receptors and transcription factors. There are also differences. T cell exhaustion is uniform in HCV infection, but varies in HBV infection depending on disease stage and/or protein target. Here, we review recent advances defining similarities and differences in T cell evasion by HBV and HCV, and the potential for reversal following antiviral therapy.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2021        PMID: 34619514      PMCID: PMC9164221          DOI: 10.1016/j.coviro.2021.08.011

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.121


  51 in total

1.  Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection.

Authors:  Nina Hensel; Zuguang Gu; Dominik Wieland; Katharina Jechow; Janine Kemming; Sian Llewellyn-Lacey; Emma Gostick; Oezlem Sogukpinar; Florian Emmerich; David A Price; Bertram Bengsch; Tobias Boettler; Christoph Neumann-Haefelin; Roland Eils; Christian Conrad; Ralf Bartenschlager; Dominic Grün; Naveed Ishaque; Robert Thimme; Maike Hofmann
Journal:  Nat Immunol       Date:  2021-01-04       Impact factor: 25.606

2.  Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection.

Authors:  Anna Schurich; Pooja Khanna; A Ross Lopes; Ki Jun Han; Dimitra Peppa; Lorenzo Micco; Gaia Nebbia; Patrick T F Kennedy; Anna-Maria Geretti; Geoffrey Dusheiko; Mala K Maini
Journal:  Hepatology       Date:  2011-05       Impact factor: 17.425

3.  OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection.

Authors:  Felix Johannes Jacobi; Katharina Wild; Maike Smits; Katharina Zoldan; Benedikt Csernalabics; Tobias Flecken; Julia Lang; Philipp Ehrenmann; Florian Emmerich; Maike Hofmann; Robert Thimme; Christoph Neumann-Haefelin; Tobias Boettler
Journal:  J Hepatol       Date:  2019-02-28       Impact factor: 25.083

4.  Early T follicular helper cell activity accelerates hepatitis C virus-specific B cell expansion.

Authors:  Eduardo Salinas; Maude Boisvert; Amit A Upadhyay; Nathalie Bédard; Sydney A Nelson; Julie Bruneau; Cynthia A Derdeyn; Joseph Marcotrigiano; Matthew J Evans; Steven E Bosinger; Naglaa H Shoukry; Arash Grakoui
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

5.  Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution.

Authors:  Victoria Kasprowicz; Yu-Hoi Kang; Michaela Lucas; Julian Schulze zur Wiesch; Thomas Kuntzen; Vicki Fleming; Brian E Nolan; Steven Longworth; Andrew Berical; Bertram Bengsch; Robert Thimme; Lia Lewis-Ximenez; Todd M Allen; Arthur Y Kim; Paul Klenerman; Georg M Lauer
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

6.  HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant.

Authors:  William S Mason; Upkar S Gill; Samuel Litwin; Yan Zhou; Suraj Peri; Oltin Pop; Michelle L W Hong; Sandhia Naik; Alberto Quaglia; Antonio Bertoletti; Patrick T F Kennedy
Journal:  Gastroenterology       Date:  2016-07-22       Impact factor: 22.682

7.  Signatures of protective memory immune responses during hepatitis C virus reinfection.

Authors:  Mohamed S Abdel-Hakeem; Nathalie Bédard; Donald Murphy; Julie Bruneau; Naglaa H Shoukry
Journal:  Gastroenterology       Date:  2014-07-16       Impact factor: 22.682

8.  TCF1+ hepatitis C virus-specific CD8+ T cells are maintained after cessation of chronic antigen stimulation.

Authors:  Dominik Wieland; Janine Kemming; Anita Schuch; Florian Emmerich; Percy Knolle; Christoph Neumann-Haefelin; Werner Held; Dietmar Zehn; Maike Hofmann; Robert Thimme
Journal:  Nat Commun       Date:  2017-05-03       Impact factor: 14.919

9.  Characterizing Hepatitis C Virus-Specific CD4+ T Cells Following Viral-Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure.

Authors:  Felicity Hartnell; Ilaria Esposito; Leo Swadling; Anthony Brown; Chansavath Phetsouphanh; Catherine de Lara; Chiara Gentile; Bethany Turner; Lucy Dorrell; Stefania Capone; Antonella Folgori; Eleanor Barnes; Paul Klenerman
Journal:  Hepatology       Date:  2020-11       Impact factor: 17.298

10.  Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C.

Authors:  Hassen Kared; Thomas Fabre; Nathalie Bédard; Julie Bruneau; Naglaa H Shoukry
Journal:  PLoS Pathog       Date:  2013-06-20       Impact factor: 6.823

View more
  1 in total

1.  Hepatic iNKT cells produce type 2 cytokines and restrain antiviral T cells during acute hepacivirus infection.

Authors:  Svjetlana Raus; Jarrett Lopez-Scarim; Joshua Luthy; Eva Billerbeck
Journal:  Front Immunol       Date:  2022-09-09       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.